Methods. Joint fluid, tissue or bone was collected from patients with PJI who were admitted to Barnes-Jewish Hospital between September 15, 2012 and April 15, 2013. PJI was defined per IDSA guidelines. Patients were considered to be culture negative or positive based on the results of routine microbiological cultures after 48 hours of incubation. DNA was extracted from samples using the MoBio Bacteremia Kit. Full length amplification of the 16S rRNA gene was performed, and PCR products were visualized using agarose gel electrophoresis. If a PCR product was present, it was sequenced and compared to GenBank and RDP to assign an organism identification per CLSI standards. Control samples were performed with each run.
Results. We collected 54 samples from 42 unique patients with culture-negative PJI including 28 (51.9%) hip, 18 (33.3%) knee, 7 (13.0%) shoulder, and 1 (1.9%) ankle samples. Sample types included tissue (31, 57.4%), fluid (13, 24.1%), and bone (10, 18.5%). Staphylococcus aureus-specific PCR was negative in all patients with culture negative PJI. 16s rRNA gene PCR was also negative in all patients with culture negative PJI. Samples were collected from 35 patients with culture positive PJI including 18 (51.4%) hip and 17 (48.6%) knee samples. Sample types included 25 (71.4%) tissue, 8 (22.9%) fluid, and 2 (5.7%) bone. S. aureus was isolated in 21 routine cultures. S. aureus-specific PCR correctly identified 12 (57.1%) of samples with S. aureus and incorrectly identified 1 sample. 16s rRNA gene PCR correctly identified 3 samples with S. aureus and 2 samples with Streptococcus spp. Two polymicrobial cultures were identified as mixed; 4 monomicrobial cultures were identified as mixed. Among those with positive cultures for S. aureus, PCR was more likely to be positive from tissue samples than all other tissue types (p = .03). Conclusion: 16s rRNA gene PCR proved to be unreliable diagnostic tool among patients with culture positive or negative PJI.
Conclusion: 16s rRNA gene PCR proved to be an unreliable diagnostic tool for patients with culture positive and negative PJI.
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